These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 22962524)

  • 1. Effect of the smell of Seirogan, a wood creosote, on dermal and intestinal mucosal immunity and allergic inflammation.
    Hiramoto K; Yamate Y; Kobayashi H; Ishii M; Miura T; Sato EF; Inoue M
    J Clin Biochem Nutr; 2012 Sep; 51(2):91-5. PubMed ID: 22962524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two cases of gastric Anisakiasis for which oral administration of a medicine containing wood creosote (Seirogan) was effective.
    Sekimoto M; Nagano H; Fujiwara Y; Watanabe T; Katsu K; Doki Y; Mori M
    Hepatogastroenterology; 2011; 58(109):1252-4. PubMed ID: 21937389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seirogan (wood creosote) inhibits stress-induced ion secretion in rat intestinal epithelium.
    Ataka K; Kuge T; Venkova K; Greenwood-Van Meerveld B
    Dig Dis Sci; 2003 Jul; 48(7):1303-9. PubMed ID: 12870787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-diarrhoeal effects of seirogan in the rat small intestine and colon examined in vitro.
    Greenwood-Van Meerveld B; Tyler K; Kuge T; Ogata N
    Aliment Pharmacol Ther; 1999 Jan; 13(1):97-102. PubMed ID: 9892885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of oncogenicity of wood creosote, the principal active ingredient of Seirogan, an herbal antidiarrheal medication, in Sprague-Dawley rats.
    Kuge T; Shibata T; Willett MS; Turck P; Traul KA
    Int J Toxicol; 2001; 20(5):297-305. PubMed ID: 11766127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of seirogan (wood creosote) on propulsive colonic motility and stool characteristics in ambulatory mini-pigs.
    Kuge T; Venkova K; Greenwood-Van Meerveld B
    Dig Dis Sci; 2002 Dec; 47(12):2651-6. PubMed ID: 12498280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stress-induced breakdown of intestinal barrier function in the rat: reversal by wood creosote.
    Kuge T; Greenwood-Van Meerveld B; Sokabe M
    Life Sci; 2006 Jul; 79(9):913-8. PubMed ID: 16643959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple-dose escalation, safety, and tolerability study of wood creosote, the principal active ingredient of seirogan, an herbal antidiarrheal medication, in healthy subjects.
    Kuge T; Shibata T; Willett MS
    J Clin Pharmacol; 2003 Mar; 43(3):284-90. PubMed ID: 12638397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter, double-blind, randomized comparison of wood creosote, the principal active ingredient of Seirogan, an herbal antidiarrheal medication, and loperamide in adults with acute nonspecific diarrhea.
    Kuge T; Shibata T; Willett MS
    Clin Ther; 2004 Oct; 26(10):1644-51. PubMed ID: 15598481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relapse of Creosote poisoning: report of a case taking Seirogan tablets].
    Kajimoto S; Tanaka T; Hirakawa A; Shinya H; Matsuo N; Nakatani T
    Chudoku Kenkyu; 2002 Jul; 15(3):293-6. PubMed ID: 12415872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wood creosote, the principal active ingredient of seirogan, an herbal antidiarrheal medicine: a single-dose, dose-escalation safety and pharmacokinetic study.
    Kuge T; Shibata T; Willett MS
    Pharmacotherapy; 2003 Nov; 23(11):1391-400. PubMed ID: 14620385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New views on antidiarrheal effect of wood creosote: is wood creosote really a gastrointestinal antiseptic?].
    Ataka K; Ito M; Shibata T
    Yakugaku Zasshi; 2005 Dec; 125(12):937-50. PubMed ID: 16327239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A historical review of the therapeutic use of wood creosote. Part II: Original plant source of crude drug wood creosote].
    Moriguchi N; Sato A; Shibata T; Yoneda Y
    Yakushigaku Zasshi; 2011; 46(1):13-20. PubMed ID: 22164686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic effect of κ-carrageenan on oxazolone-induced inflammation in BALB/c mice.
    Wu W; Wang F; Gao X; Niu T; Zhu X; Yan X; Chen H
    BMC Gastroenterol; 2016 Mar; 16():41. PubMed ID: 27015810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective role of 1,25(OH)2 vitamin D3 in the mucosal injury and epithelial barrier disruption in DSS-induced acute colitis in mice.
    Zhao H; Zhang H; Wu H; Li H; Liu L; Guo J; Li C; Shih DQ; Zhang X
    BMC Gastroenterol; 2012 May; 12():57. PubMed ID: 22647055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventive oral supplementation with
    Ribeiro WR; Queiroz AG; Mendes E; Casaro MB; Nascimento CM; Coelho LSSF; Martins FS; Leite-Silva VR; Ferreira CM
    Benef Microbes; 2021 Apr; 12(2):199-209. PubMed ID: 33573507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhalation and dermal exposure of workers during timber impregnation with creosote and subsequent processing of impregnated wood.
    Hebisch R; Karmann J; Schäferhenrich A; Göen T; Berger M; Poppek U; Roitzsch M
    Environ Res; 2020 Feb; 181():108877. PubMed ID: 31722805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rectal Delivery of a DNAzyme That Specifically Blocks the Transcription Factor GATA3 and Reduces Colitis in Mice.
    Popp V; Gerlach K; Mott S; Turowska A; Garn H; Atreya R; Lehr HA; Ho IC; Renz H; Weigmann B; Neurath MF
    Gastroenterology; 2017 Jan; 152(1):176-192.e5. PubMed ID: 27639807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary adenylate cyclase-activating polypeptide deficiency enhances oxazolone-induced allergic contact dermatitis in mice.
    Kemény A; Reglodi D; Cseharovszky R; Hashimoto H; Baba A; Szolcsányi J; Pintér E; Helyes Z
    J Mol Neurosci; 2010 Nov; 42(3):443-9. PubMed ID: 20414744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of several mediators of inflammation on the mouse hypothalamo-pituitary-adrenal axis response during acute endotoxemia.
    Hadid R; Spinedi E; Chautard T; Giacomini M; Gaillard RC
    Neuroimmunomodulation; 1999; 6(5):336-43. PubMed ID: 10474052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.